SMARTCAD | COVID-19: A New System in the Fight Against COVID-19

Thirona Teams Up with Smart Reporting to Further Improve COLVID-19 Detection

With the COVID-19 pandemic ongoing, Thirona starts a new collaboration to further improve and accelerate the detection of the virus. SmartCAD | COVID-19 is a software product that combines Thirona’s CAD4COVID-CT algorithm with the popular COVID-19 reporting template developed by digital health company Smart Reporting.

The innovative new system enables direct analysis of chest CT images with CAD4COVID-CT and transfers the results straight into a structured report. The output includes a COVID-19 severity score on lung and lobar level, the percentage of abnormalities detected for each lobe and the lungs overall, and the percentage of lobar emphysema. This way, SmartCAD | COVID-19 combines radiologist’s findings with the data of the CAD4COVID-CT AI algorithm in an insightful way. It is fast, cloud-based, and provided free-of-charge in support of the fight against the pandemic.

Support in diagnosis, evaluation, and documentation: Smart Reporting offers templates for radiologists to record their insights on a patient’s clinical status. Thirona’s CAD4COVID-CT algorithm results are now integrated in the COVID-19 template to support in the diagnosis of suspected cases. CAD4COVID-CT software uses a single inspiratory chest CT scan in the form of a DICOM image and results can be sent straight into the Smart Reporting template. SmartCAD | COVID-19 provides a structured approach to report abnormal findings in chest CT, highlighting findings that may be associated with COVID-19 affecting the lungs. The report includes not only findings by the radiologist but also pre-filled insights offered by the CAD4COVID-CT AI algorithm. It can be used as support in diagnosis, evaluation, and documentation of pulmonary tissue images from CT thoracic datasets.

Used by radiologists worldwide: Dr. Thomas Huber, Senior Clinical Product Manager at Smart Reporting, about SmartCAD | COVID-19: “Thanks to our long-standing cooperation with Thirona we could quickly react to a pandemic like the one we are facing now and integrate the CAD4COVID-CT software into our reporting template. It provides a semi-automatic workflow that assists physicians in diagnosing the virus. Our free structured templates are used by radiologists worldwide, making this new addition an easy next step.” Dr. Eva van Rikxoort, Managing Director of Thirona, adds: “CAD4COVID-CT can not only detect if someone is infected with the virus but also quantify how much and which parts of the lungs are affected. And because AI is available 24/7, patients always get the same high-quality analysis of their scan. It is a new tool in helping to find active cases, so healthcare professionals can react accordingly. Through the collaboration with Smart Reporting, CAD4COVID-CT is instantly accessible to 10,000 radiologists that are already registered on the platform.”

SourceThirona

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version